In VitroOsteogenic Differentiation of Rat Bone Marrow Cells Subcultured with and without Dexamethasone
- 1 April 2002
- journal article
- research article
- Published by Mary Ann Liebert Inc in Tissue Engineering
- Vol. 8 (2) , 321-331
- https://doi.org/10.1089/107632702753725076
Abstract
The aim of our study was to investigate the osteogenic potential of subcultured rat bone marrow cells. Rat bone marrow (RBM) cells were cultured with or without dexamethasone. Subsequently, osteogenic differentiation and expression was studied. When cells were cultured continuously in the presence of dexamethasone, cultures initially showed high alkaline phosphatase expression and abundant mineralization. Expression of differentiation markers decreased with passaging. After cells were passaged three times, no alkaline phosphatase activity and calcification were found. Primary cells cultured without dexamethasone showed low alkaline phosphatase and no calcification, and remained fibroblast-like. When these cells were subcultured in the presence of dexamethasone, the cells did show osteogenic differentiation. Nevertheless, this occurred at a significant lower level than with cells continuously cultured with dexamethasone. In addition, no differentiation was found after second passage. Our results indicate that subcultured undifferentiated RBM cells show osteogenic differentiation after addition of dexamethasone. Expression of alkaline phosphatase and mineralization is higher in cells continuously supplemented with dexamethasone. Still, even when dexamethasone is added continuously, RBM cells loose their osteogenic potential after several passages. Therefore, we conclude that subculture of undifferentiated rat bone marrow cells results in the loss of osteogenic potential of these cells.Keywords
This publication has 41 references indexed in Scilit:
- Mesenchymal stem cellsExperimental Hematology, 2000
- Adult rat and human bone marrow stromal cells differentiate into neuronsJournal of Neuroscience Research, 2000
- Human bone cell cultures in biocompatibility testing. Part I: osteoblastic differentiation of serially passaged human bone marrow cells cultured in α-MEM and in DMEMBiomaterials, 2000
- Future potentials for using osteogenic stem cells and biomaterials in orthopedicsBone, 1999
- Osteoprogenitor cell frequency in rat bone marrow stromal populations: Role for heterotypic cell–cell interactions in osteoblast differentiationJournal of Cellular Biochemistry, 1999
- Advances in the osteoblast lineageBiochemistry and Cell Biology, 1998
- Human bone tissue formation in diffusion chamber culture in vivo by bone-derived cells and marrow stromal fibroblastic cellsBone, 1995
- Bone marrow cells are targets for the anabolic actions of prostaglandin E2 on bone: Induction of a transition from nonadherent to adherent osteoblast precursorsJournal of Bone and Mineral Research, 1995
- Characterization of cells with osteogenic potential from human marrowBone, 1992
- Osteogenic potential of culture-expanded rat marrow cells as assayed in vivo with porous calcium phosphate ceramicBiomaterials, 1991